Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDD versus Lactobacillus plantarum 299V plus fibre for prevention of ICU-acquired infections
NL-OMON27737Suspended
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2005
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of lactobacillus plantarum 299v, colistin, gentamicin, amphotericin b and cefotaxime, sponsored by Maastricht University Medical Center+. Started Jun 2005; status: suspended.
02
Drugs
lactobacillus plantarum 299vcolistingentamicinamphotericin bcefotaxime
Beyond the preview
Go deeper on NL-OMON27737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27737.